As of 10:31 AM on the 26th, Humasis is trading at 10,700 KRW, down 0.93% from the previous day. This marks a 235.95% increase compared to June 9. Humasis is known as an in vitro diagnostic device company.
Today, foreigners have a net purchase of 11,000 shares of Humasis, while institutions have a net sale of 7,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 512,846 shares, while foreigners and institutions have net sold 180,846 shares and 161,650 shares, respectively.
On June 25, Humasis became a market issue with the headline "Plunges to lower limit after 6 consecutive gains."

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
